Convergint stands as a premier provider of DEA-validated vault and cage solutions, with demonstrated expertise in solutions for the pharmaceutical industry. For over forty years, Convergint CustomVault has been at the forefront of designing modular vault systems and wire cages that meet the rigorous standards of 21 CFR 1301.72 for the secure storage of Schedule I, II, III, IV, and V controlled substances. The service portfolio includes design, engineering, installation, and service for modular vaults based at pharmaceutical manufacturers, pharmaceutical distributors, and healthcare facilities requiring DEA-compliant physical security. Ultimately, Convergint CustomVault provides customized solutions and outstanding service end to end as evidenced in the following use case.
Review this use case to learn how Convergint emphasizes the critical role of robust security infrastructure in protecting pharmaceutical companies’ assets, data, and operations from diverse industry threats.
Effective security and safety is a multi-layered approach involving people, processes, and technologies. Convergint-provided products and services are only one part of this multi-layered approach, will not detect or prevent all threats or solve every risk, and should not be your sole method of security or safety. Please see the “IMPORTANT PRODUCT SAFETY AND SERVICE INFORMATION” documentation, available at convergint.com/terms, prior to using a Convergint-installed system.
